These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 2380010)

  • 21. Positron emission tomography for the assessment of myocardial viability.
    Schelbert HR
    Circulation; 1991 Sep; 84(3 Suppl):I122-31. PubMed ID: 1884478
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Myocardial metabolism and perfusion assessed by positron emission tomography].
    Torizuka K; Tamaki N; Yonekura Y; Yamashita K; Ohtani H; Magada Y; Fujibayashi Y; Fujita T; Sasayama S; Konishi J
    Kokyu To Junkan; 1990 Apr; 38(4):309-20. PubMed ID: 2194256
    [No Abstract]   [Full Text] [Related]  

  • 23. Positron computed tomography for the in vivo assessment of regional myocardial function.
    Schelbert HR; Phelps ME
    J Mol Cell Cardiol; 1984 Aug; 16(8):683-93. PubMed ID: 6332919
    [No Abstract]   [Full Text] [Related]  

  • 24. [Positron-emission tomography (PET) in the evaluation of metabolic processes in the myocardium].
    Haubold-Reuter B; Haldemann R; Amann F; Turina J; Reist W; Leenders K; von Schulthess GK
    Schweiz Med Wochenschr; 1992 Jan; 122(1-2):14-21. PubMed ID: 1594901
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Positron emission tomography in human myocardial ischemia.
    Schelbert HR; Schwaiger M
    Herz; 1987 Feb; 12(1):22-40. PubMed ID: 3493961
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Mikamo lecture. Probing the heart's biochemistry with positron emission tomography.
    Schelbert HR
    Jpn Circ J; 1986 Jan; 50(1):1-29. PubMed ID: 3486300
    [No Abstract]   [Full Text] [Related]  

  • 27. [Glucose metabolism in myocardium and an assessment of myocardial viability by 18FDG-PET].
    Ogiu N; Nakai K; Hiramori K
    Nihon Rinsho; 1994 Jul; 52 Suppl(Pt 1):636-40. PubMed ID: 12436594
    [No Abstract]   [Full Text] [Related]  

  • 28. The character of transient myocardial ischemia: clinical studies and progress using positron emission tomography.
    Selwyn AP; Shea M; Deanfield J; Wilson R; DeLandsheere C; Jones T
    Int J Card Imaging; 1985; 1(1):61-72. PubMed ID: 3916484
    [No Abstract]   [Full Text] [Related]  

  • 29. [Radioisotope explorations in cardiologic practice].
    Itti R; Brochier M; Lorgeron JM; Philippe L; Charbonnier B; Benjelloun H
    Ann Med Interne (Paris); 1983; 134(6):581-7. PubMed ID: 6360011
    [No Abstract]   [Full Text] [Related]  

  • 30. [Results of fatty acid SPECT of the myocardium in coronary disease].
    Reske SN; Knapp FF; Nitsch J; Kropp J; Reichmann K; Winkler C
    Nuklearmedizin; 1986 Jun; 25(3):90-8. PubMed ID: 3489223
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Euglycemic hyperinsulinemic clamp and oral glucose load in stimulating myocardial glucose utilization during positron emission tomography.
    Schelbert HR
    J Nucl Med; 1992 Jul; 33(7):1263-6. PubMed ID: 1613562
    [No Abstract]   [Full Text] [Related]  

  • 32. [Assessment of myocardial circulation and metabolism using positron CT].
    Shishido F; Uemura K; Kanno I; Murakami M; Ono Y; Takahashi A
    J Cardiol Suppl; 1987; 15():61-3. PubMed ID: 3509906
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nuclear cardiology (first of two parts).
    Berger HJ; Zaret BL
    N Engl J Med; 1981 Oct; 305(14):799-807. PubMed ID: 6267467
    [No Abstract]   [Full Text] [Related]  

  • 34. Positron emission tomography as an aid in understanding electrocardiographic changes of ischemia, infarction, and cardiomyopathy.
    Grover-McKay M
    Ann N Y Acad Sci; 1990; 601():77-94. PubMed ID: 2221703
    [No Abstract]   [Full Text] [Related]  

  • 35. [Application of data processing. d. Positron CT].
    Torizuka K; Yonekura Y; Tamaki N; Saji H
    Nihon Rinsho; 1984 Dec; 42(12):2775-80. PubMed ID: 6397639
    [No Abstract]   [Full Text] [Related]  

  • 36. Myocardial perfusion studies: lessons from a decade of clinical use.
    Strauss HW; Boucher CA
    Radiology; 1986 Sep; 160(3):577-84. PubMed ID: 3526397
    [No Abstract]   [Full Text] [Related]  

  • 37. [Identification of viable myocardium: current goal in ischemic heart disease with ventricular dysfunction].
    Marin-Neto JA; Bonow RO
    Arq Bras Cardiol; 1991 Jul; 57(1):1-3. PubMed ID: 1823754
    [No Abstract]   [Full Text] [Related]  

  • 38. Myocardial perfusion imaging in the diagnosis of coronary artery disease.
    Go RT; MacIntyre WJ; Cook SA; Neumann DR
    Curr Opin Radiol; 1992 Aug; 4(4):23-33. PubMed ID: 1627448
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Automated quantitation of three-dimensional cardiac positron emission tomography for routine clinical use.
    Hicks K; Ganti G; Mullani N; Gould KL
    J Nucl Med; 1989 Nov; 30(11):1787-97. PubMed ID: 2809743
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The integration of positron emission tomography into noninvasive cardiovascular diagnosis].
    Nitzsche EU; Müller P; Czernin J; Moser E; Schelbert HR
    Radiologe; 1992 Jun; 32(6):266-75. PubMed ID: 1641484
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.